|
Pharma Marketing News is the monthly newsletter of the Pharma Marketing Network. It is distributed FREE to registered subscribers via email and the Web. Editorial & Advisory Board We accept advertising relevant to the interests of our subscribers. For more information, see: Published by: VirSci Corporation PO Box 760 Newtown, PA 18940 215-504-4164 215-504-5739 (FAX) E-mail: infovirsci@virsci.com |
![]() Pharma Marketing News | Subscribe | Discussion Forums | Roundtable | Podcasts | Blog Daily News Briefs | Surveys | Resources/Links | Glossary | Case Studies | Reports Pharma Marketing Vendor Directory | Conference Calendar | Pharma Jobs Advertising Information | FAQs | About Us | Privacy Policy When Is Commercial Support Appropriate for CME Activities?
SUMMARY
This article summarizes when it is and is not appropriate for pharmaceutical companies to support independent CME programs.
John Ukropec, PhD, Sr. Manager at Wyeth Pharmaceuticals, agreed that the thrust and purpose of CME is nicely summarized in the preamble to the ACCME guidelines, namely "The purpose of CME is to enhance the physician's ability to care for patients. It is the responsibility of the accredited provider of the CME activity is designed primarily for that purpose." He was speaking at the Barnett International conference, "Defining the Value of Continuing Medical Education" held on March 13th and 14th 2004 in Philadelphia.
Charts based upon data from the latest ACCME annual reports show the growth in commercial support for CME.
PMN34-03 |
|
© 2004-2008. VirSci Corporation. All rights reserved.